Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 646K | - |
| Gross profit | -4.9M | - |
| Net profit | -6.37M | - |
| EBITDA | -5.43M | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €10.76M |
Number of shares | 52.76M |
52-week high/low | €0.47 - €0.18 |
| Dividends | No |
Beta | 0.54 |
P/E ratio | -0.76 |
PEG ratio | 0.01 |
P/B ratio | -0.84 |
P/S ratio | 5.36 |
Company profile
Intrasense SA designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. The company offers Myrian Imaging Layer, a multimodal visualization software platform suite for health industrials; Myrian Studio, a solution for the development of medical imaging applications for innovators, industrial clients, spin-offs, and research labs; and Myrian technologies to develop biomarkers and artificial intelligence solutions. It also provides Myrian Clinical Apps, a portfolio of clinical applications for advanced post-processing, which include Myrian XP-Breast; Myrian XP-Prostate; Myrian XP-Liver; Myrian XP-Mammo; Myrian XP-Lung; Myrian XP-Colon; Myrian XL-Onco, a lesion tracking solutions; Myrian XP-Vessel; Myrian XP-Cardiac; solution for pathology or organ; and various tools for the analysis of MRI, CT, conventional, radiology, and nuclear imaging exams. The company was incorporated in 2004 and is headquartered in Montpellier, France.
| Name | Intrasense |
| CEO | Stephen Armand |
| Headquarters | Montpellier,
occ France |
| Website | |
| IPO | 02/22/2012 |
| Employees | 76 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Euronext | ALINS.PA |
Frankfurt | I8S.F |
Paris | ALINS.PA |